Patents

RECENT NEWS
StreetInsider.com  Aug 29  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/United+Therapeutics+%28UTHR%29+Confirms+Favorable+Ruling+in+Remodulin+Patent+Case/9793821.html for the full story.
Benzinga  Aug 28  Comment 
Neonode Inc., (Nasdaq: NEON), the optical-touch technology licensing company, announced today, that on August 19 the US Patent and Trademark Office (USPTO) issued patent #8,812,993 ('993) for sweep gestures. The '993 patent has 136 patent...
DailyFinance  Aug 28  Comment 
NEWARK, DE -- (Marketwired) -- 08/28/14 -- iBio, Inc. (NYSE MKT: IBIO), a leader in plant-based biotechnology for developing and manufacturing biological products, received notices of intention to grant for two European patent applications...
The Hindu Business Line  Aug 28  Comment 
IBM inventors have patented a technique that helps clients automatically analyse and manage the location where their public and private cloud data is stored, thereby enabling companies to comply w...
The Straits Times  Aug 27  Comment 
August 28, 2014 1:22 AM A LOCAL start-up has devised a system that lets people quickly search the database of hundreds of millions of patents granted worldwide.
TechCrunch  Aug 27  Comment 
 If Disney isn’t already the most magical place on earth, it soon will be. The mega-amusement park has filed three patents to use drones within the park, first spotted by MarketWatch. Within the patents, Disney lists a few different use cases...
DailyFinance  Aug 27  Comment 
ATLANTA, GA and WARSAW, POLAND--(Marketwired - August 27, 2014) - Perma-Fix Medical S.A. (WARSAW: PFM), a subsidiary of Perma-Fix Environmental Services, Inc. (NASDAQ: PESI), and developer of a reliable, cost effective, non-uranium process to...
DailyFinance  Aug 27  Comment 
DEERFIELD, IL -- (Marketwired) -- 08/27/14 -- Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that the United States Patent and Trademark Office (USPTO) has issued Horizon a Notice of Allowance for U.S. patent application number 13/860,015...
TechCrunch  Aug 26  Comment 
 Back in 2013, Google announced its plans to not sue anybody who had implemented open-source versions of its MapReduce algorithm. Since then, the company has expanded what it calls its “Open Patent Non-Assertion Pledge” to a number of other...
StreetInsider.com  Aug 26  Comment 
Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Genetic+Technologies+%28GENE%29+Stock+Advances+After+Announcing+Patent+Victory/9782362.html for the full story.




 
TOP CONTRIBUTORS

Patents

Patent is the right to ownership,as part of an intellectual property law, where by a person / organization discovers a lesser known concept or invents something new and holds sole intellectual ownership rights to that particular idea. These are usually published / granted after a lot of research and exhaustive verification. Patents are generally registered with United States Patent and Trademark Office, an Agency Of The United States Department Of Commerce, in the United States and The Intellectual Property Office,a division of the Department for Innovation, Universities & Skills in the United Kingdom.

Technological Patents

Pharmaceutical Patents

Pharmaceutical patents protect manufacturers of prescription drugs, prohibiting others from producing a drug during the length of its patent protection. The length of these patents varies in different countries, though they are usually between 15-20 years. In the U.S., a pharmaceutical patent is valid for 20 years. Drug companies usually apply for patent protection before they actually begin producing the drug, opting instead to secure their rights to a particular compound at the beginning of the testing process. By the time a drug comes to market, there may only be 8-10 years of patent protection remaining, which is significantly less than the 20 offered by the patent. Companies often attempt to extend these patents by making slight reformulations of the original compound or proving its effectiveness at treating a condition other than the one for which it was originally granted a patent. This is referred to as "evergreening", a practice which many criticize.

For further information on the process of obtaining pharmaceutical patents and regulatory approval, see Clinical Trials and FDA Approval.

For more information about pharmaceutical patents in relation to generic versions of drugs, see Generic Drugs.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki